Based on SEC filing data. A biotechnology corporation founded in 2017 and based in Cambridge, MA has raised $82.6M in equity funding at the growth stage. The company operates in the biotech sector.
Get notified the moment Cedilla Therapeutics, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.